Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

Mycenax becomes Taiwan's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System

TAIPEI, May 18, 2021 /PRNewswire/ -- Mycenax (TWSE: 4726) becomes one of the first CDMO companies inAsia to adapt the Beacon Optofluidic system to cell line development services. Mycenax adopted Beacon® Optofluidic System, a high throughput selection system for single-cell cloning and quantifica...

2021-05-18 10:32 12755

Hummingbird Bioscience Raises US$125 Million in Series C Financing

* Investment round led by Novo Holdings, joined by a syndicate of international biotech investors * Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision therapeutics * Kenneth Harrison from Novo Ventures ...

2021-05-18 09:35 2271

Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients

SINGAPORE, May 18, 2021 /PRNewswire/ -- Farrer Park Hospital has introduced the pressurized intraperitoneal aerosolized chemotherapy (PIPAC) treatment for patients with peritoneal cancer, off...

2021-05-18 08:15 1721

AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community

The "AIforCOVID Imaging Archive" platform enables the sharing of radiographic images from COVID-19 patients and development of leading-edge Artificial Intelligence-based methods for predicting clinical developments of the disease caused by SARS-CoV-2. The platform has been promoted and implement...

2021-05-18 04:44 1250

AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community

ISMRM Awards Gold Medals At Annual Meeting And Announces New President

CONCORD, Calif., May 17, 2021 /PRNewswire/ -- The International Society for Magnetic Resonance in Medicine (ISMRM) is holding its Annual Meeting this week and will recognize several achievements with prestigious awards. The Gold Medal award is the organization's highest honor and is awarded to r...

2021-05-17 23:00 1741

EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines

PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...

2021-05-17 20:54 1623

Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037)

SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in he...

2021-05-17 20:35 3217

INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors

Dr. Dansey, Seagen's Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development Appointment of industry leader in drug development expands the Board's diverse industry, clinical development, research and commercialization expertise PLYMOUTH MEETING, Pa., May 17, 20...

2021-05-17 20:00 3389

Everest Medicines Announces China NMPA Has Accepted Biologics License Application for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer

SHANGHAI, May 17, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products inGreater China and other parts of Asia, announced today that the C...

2021-05-17 16:51 3007

Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London

Industry-leading Centre will provide new collaborative and experiential environment for research, training, and treatments LONDON, May 17, 2021 /PRNewswire/ -- Cynosure announced today the grand opening of its new Cynosure Experience Centre inLondon. Complete with new research and training facil...

2021-05-17 16:00 1421

Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London

Nippon Express (China) Becomes First Japanese Company to Acquire GDP Certification in China

TOKYO, May 17, 2021 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a local subsidiary of Nippon Express Co., Ltd., has obtained Good Distribution Practice (GDP) certification, effectiveMonday, March 29, 2021, for its Shanghai Pudong Airport CFS, making it the first Jap...

2021-05-17 15:00 1954

Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, May 17, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2021-05-17 09:00 3770

ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension

PALO ALTO, Calif., May 17, 2021 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO ("TRIO") study. In subjects with resistant hypertension, t...

2021-05-17 08:24 1375

Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial

SHANGHAI and HONG KONG, May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and onc...

2021-05-17 08:00 2458

myMedidata Wins 'Best Patient Portal' Award in 2021 MedTech Breakthrough Awards Program

SINGAPORE, May 14, 2021 /PRNewswire/ -- Medidata , a Dassault Systèmes company, the global leader in creating end-to-end solutions supporting the entire clinical trial process, today announced that its myMedidata

2021-05-14 11:00 2588

Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China

SHANGHAI and HONG KONG, May 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-05-14 08:40 2826

WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

WUXI, China, May 14, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end ...

2021-05-14 08:30 4416

Transcenta Announces Updated Clinical Data from Phase I Study of pH-Dependent PD-L1 Antibody MSB2311 to Be Presented at the 2021 ASCO Annual Meeting

SUZHOU, China, May 14, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced that the updated phase I clinical da...

2021-05-14 08:00 1831

Antengene Announces the Completion of Its Manufacturing Center in Shaoxing to Accelerate the Commercialization of Novel Anti-Cancer Therapies

SHANGHAI and HONG KONG, May 14, 2021 /PRNewswire/ -- Today, Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) successfully hosted an inauguration ceremony for its manufacturing center at the Binhai Life Science and Healthcare Industrial Zone in Shaoxing. The completion of the manufacturi...

2021-05-14 08:00 3693

Antengene Announces the Completion of Its Manufacturing Center in Shaoxing to Accelerate the Commercialization of Novel Anti-Cancer Therapies

Improving Cancer Survival Prediction: A New Approach with EpiVax Therapeutics' Ancer Platform

PROVIDENCE, R.I., May 14, 2021 /PRNewswire/ -- EpiVax Therapeutics, Inc. ("EVT") announces the publication"Multi–step screening of neoantigens' HLA and TCR–interfaces improves prediction of survival" inScientific Reports. This study demonstrates a superior method of survival analysis for cancer p...

2021-05-14 00:28 1679

1 ... 243 244 245246247 248 249 ... 383